Anti Inflammatory Peptides Market

Anti-inflammatory Peptides Market

  • HC-2525
  • 4.6 Rating
  • 200 Pages
  • Upcoming
  • 76 Reviews
  • PDF Excel PPT
raksha

Author :

Raksha Sharma

Vineet

Fact-checked by :

Vineet Pandey

Vishal

Editor :

Vishal Golekar

The global anti-inflammatory peptides market size is estimated to register a considerable CAGR during the forecast period, 2021-2028. The growth of the market is attributed to the rising prevalence of disorders including psoriasis, multiple sclerosis, autoimmune diseases, and inflammatory bowel diseases.

Increasing awareness among patients regarding the timely treatment of such disorders is another key factor driving the market growth.

Global Anti Inflammatory Peptides Market Key Takeaways

Anti-inflammatory peptides are small but useful elements that suppress or slow down the inflammation of a mammal’s skin, mucous membranes, and injury in the lungs’ air spaces. As per the reports by the World Psoriasis Day Consortium, approximately 130 million people are affected by this disease globally which is about 3% to 4% of the total population. One of the reports by the World Health Organization (WHO) states that about 30 out of 100,000 individuals are affected by multiple sclerosis. The two major inflammatory bowel diseases that are most common are ulcerative colitis and Crohn’s disease as their prevalence are more in the urban areas as compared to rural areas.

Market Trends, Drivers, Restraints, and Opportunities

  • Increasing geriatric population base leads to weakening of natural immunity in the direction of the pro-inflammatory status of the human body, which is expected to drive the market growth.
  • Adoption of unhealthy lifestyle among a large number of the global population coupled with increasing obesity among them are expected to propel the market during the forecast period.
  • Presence of advanced and well-established healthcare infrastructures in the developed regions is anticipated to drive the market expansion in the coming years.
  • Expiration of patents of branded drugs coupled with side-effects caused due to anti-inflammatory drugs are key challenges that can hamper the market growth.
  • Ongoing research to discover new and effective anti-inflammatory peptides is projected to create lucrative opportunities for market growth during the forecast period.

Scope of the Report

The report on the global anti-inflammatory peptides market includes an assessment of the market, trends, and segments. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Anti-inflammatory Peptides Market – Global Industry Analysis, Growth, Share, Size, Trends, And Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Applications (Gastrointestinal Diseases, Cardiovascular Diseases, Neurological Diseases, Dermatological Diseases, Ophthalmological & Orthino Diseases, Renal Diseases, Transplantation, Respiratory Diseases & Pulmonary, and Rheumatological & Autoimmune Diseases)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Abbvie Corp.; Novartis AG; Merck Serono; Rogne Bioscience; F4 Pharma; Digna Biotech; Araim Pharmaceuticals, Inc.; and Mylan Pharmaceuticals

Market Segment Insights

Cardiovascular diseases segment is expected to dominate the market

On the basis of applications, the global anti-inflammatory peptides market is segmented into gastrointestinal diseases, cardiovascular diseases, neurological diseases, dermatological diseases, ophthalmological & orthino diseases, renal diseases, transplantation, respiratory diseases & pulmonary, and rheumatological & autoimmune diseases. Among all the segments, the cardiovascular diseases segment held a major share of the market in 2019 and is expected to dominate the market during the forecast period. The segment growth is attributed to the global increasing incidence of cardiovascular diseases among a large number of the global population.

Global Anti Inflammatory Peptides Market Applications

Asia Pacific is anticipated to expand at a lucrative growth rate

In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America accounted for a key share of the market in 2019 and is projected to constitute a considerable market share during the projected period attributed to the presence of strong research & development, technologically advanced systems, and high awareness levels among the patients in the region. Moreover, other factor contributing to the segment growth is due to the increasing prevalence of psoriasis and multiple sclerosis. As per the survey in 2013 by the National Psoriasis Foundation, approximately 7.6 million individuals are affected with psoriasis and 400,000 new cases were registered in the same year in the U.S.

On the other hand, the market in Latin America is also expected to witness a healthy growth rate in the coming years due to the rise of public and private associations, which leads to an increase in investment in the market. However, the market of Asia Pacific is anticipated to expand at a lucrative growth rate during the projected period attributed to the improvement of healthcare infrastructure at a fast pace in the region. Some other major factors driving the market expansion are the increasing level of awareness among patients and the rise in the number of patients in the region.

Global Anti Inflammatory Peptides Market Regions

Segments

The global anti-inflammatory peptides market has been segmented on the basis of

Applications

  • Gastrointestinal Diseases
  • Cardiovascular Diseases
  • Neurological Diseases
  • Dermatological Diseases
  • Ophthalmological & Orthino Diseases
  • Renal Diseases
  • Transplantation
  • Respiratory Diseases & Pulmonary
  • Rheumatological & Autoimmune Diseases

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Abbvie Corp.
  • Novartis AG
  • Merck Serono
  • Rogne Bioscience
  • F4 Pharma
  • Digna Biotech
  • Araim Pharmaceuticals, Inc.
  • Mylan Pharmaceuticals

Competitive Landscape

Key players competing in the global anti-inflammatory peptides market are Abbvie Corp.; Novartis AG; Merck Serono; Rogne Bioscience; F4 Pharma; Digna Biotech; Araim Pharmaceuticals, Inc.; and Mylan Pharmaceuticals. Many of these players have adopted business strategies such as development of novel drugs, launch of new products, technology advancement, partnerships, mergers, and production capacity expansion in order to increase their expansion, their consumer base, and market position globally.

Global Anti Inflammatory Peptides Market Key Players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Anti-inflammatory Peptides Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Anti-inflammatory Peptides Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Anti-inflammatory Peptides Market - Supply Chain
  4.5. Global Anti-inflammatory Peptides Market Forecast
     4.5.1. Anti-inflammatory Peptides Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Anti-inflammatory Peptides Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Anti-inflammatory Peptides Market Absolute $ Opportunity
5. Global Anti-inflammatory Peptides Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Anti-inflammatory Peptides Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Anti-inflammatory Peptides Demand Share Forecast, 2019-2026
6. North America Anti-inflammatory Peptides Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Anti-inflammatory Peptides Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Anti-inflammatory Peptides Demand Share Forecast, 2019-2026
7. Latin America Anti-inflammatory Peptides Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Anti-inflammatory Peptides Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Anti-inflammatory Peptides Demand Share Forecast, 2019-2026
8. Europe Anti-inflammatory Peptides Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Anti-inflammatory Peptides Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Anti-inflammatory Peptides Demand Share Forecast, 2019-2026
9. Asia Pacific Anti-inflammatory Peptides Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Anti-inflammatory Peptides Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Anti-inflammatory Peptides Demand Share Forecast, 2019-2026
10. Middle East & Africa Anti-inflammatory Peptides Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Anti-inflammatory Peptides Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Anti-inflammatory Peptides Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Anti-inflammatory Peptides Market: Market Share Analysis
  11.2. Anti-inflammatory Peptides Distributors and Customers
  11.3. Anti-inflammatory Peptides Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)

Purchase Premium Report